Inhibitory effects of resveratrol on airway remodeling by transforming growth factor-β/smad signaling pathway in chronic asthma model

Allergy, Asthma and Immunology Research

Volumn 9, Issue 1, 2017, Pages 25-34

  Lee, Hwa Young ^a   Kim, In Kyoung ^a   Yoon, Hyoung Kyu ^a   Kwon, Soon Suk ^a   Rhee, Chin Kook ^a   Lee, Sook Young ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Airway remodeling; Resveratrol; TGF 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; RESVERATROL; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA1; VIMENTIN;

AIRWAY EPITHELIUM CELL; AIRWAY REMODELING; ALLERGIC AIRWAY INFLAMMATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BRONCHUS; CELL HYPERPLASIA; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; EOSINOPHIL COUNT; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE REPRESSION; GOBLET CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LEUKOCYTE DIFFERENTIAL COUNT; LUNG LAVAGE; LUNG PARENCHYMA; MESENCHYME; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SENSITIZATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; WESTERN BLOTTING;

EID: 85007564199     PISSN: 20927355     EISSN: 20927363     Source Type: Journal    
DOI: 10.4168/aair.2017.9.1.25     Document Type: Article

References (32)

1. Elias JA, Lee CG, Zheng T, Ma B, Homer RJ, Zhu Z. New insights into the pathogenesis of asthma. J Clin Invest 2003;111:291-7.
2. Pain M, Bermudez O, Lacoste P, Royer PJ, Botturi K, Tissot A, et al. Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype. Eur Respir Rev 2014;23:118-30.
3. Durrani SR, Viswanathan RK, Busse WW. What effect does asthma treatment have on airway remodeling? Current perspectives. J Allergy Clin Immunol 2011;128:439-48.
4. Manuyakorn W, Howarth PH, Holgate ST. Airway remodelling in asthma and novel therapy. Asian Pac J Allergy Immunol 2013;31:3-10.
5. Usmani OS. Small airways dysfunction in asthma: evaluation and management to improve asthma control. Allergy Asthma Immunol Res 2014;6:376-88.
6. Sposato B, Scalese M, Migliorini MG, Di Tomassi M, Scala R. Small airway impairment and bronchial hyperresponsiveness in asthma onset. Allergy Asthma Immunol Res 2014;6:242-51.
7. Makino S, Sagara H. Evolution of asthma concept and effect of current asthma management guidelines. Allergy Asthma Immunol Res 2010;2:172-6.
8. Chang WS, Kim EJ, Lim YM, Yoon D, Son JY, Park JW, et al. Age-related changes in immunological factors and their relevance in allergic disease development during childhood. Allergy Asthma Immunol Res 2016;8:338-45.
9. Chen Y, Wong GW, Li J. Environmental exposure and genetic predisposition as risk factors for asthma in China. Allergy Asthma Immunol Res 2016;8:92-100.
10. Hay ED. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn 2005;233: 706-20.
11. Bartis D, Mise N, Mahida RY, Eickelberg O, Thickett DR. Epithelialmesenchymal transition in lung development and disease: does it exist and is it important? Thorax 2014;69:760-5.
12. Hackett TL. Epithelial-mesenchymal transition in the pathophysiology of airway remodelling in asthma. Curr Opin Allergy Clin Immunol 2012;12:53-9.
13. Wood LG, Wark PA, Garg ML. Antioxidant and anti-inflammatory effects of resveratrol in airway disease. Antioxid Redox Signal 2010; 13:1535-48.
14. Royce SG, Dang W, Yuan G, Tran J, El Osta A, Karagiannis TC, et al. Resveratrol has protective effects against airway remodeling and airway hyperreactivity in a murine model of allergic airways disease. Pathobiol Aging Age Relat Dis 2011;1:7134.
15. Lee M, Kim S, Kwon OK, Oh SR, Lee HK, Ahn K. Anti-inflammatory and anti-asthmatic effects of resveratrol, a polyphenolic stilbene, in a mouse model of allergic asthma. Int Immunopharmacol 2009; 9:418-24.
16. Wang H, Zhang H, Tang L, Chen H, Wu C, Zhao M, et al. Resveratrol inhibits TGF-beta1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis. Toxicology 2013;303:139-46.
17. Ji Q, Liu X, Han Z, Zhou L, Sui H, Yan L, et al. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-beta1/Smads signaling pathway mediated Snail/Ecadherin expression. BMC Cancer 2015;15:97.
18. Xiao Z, Chen C, Meng T, Zhang W, Zhou Q. Resveratrol attenuates renal injury and fibrosis by inhibiting transforming growth factorbeta pathway on matrix metalloproteinase 7. Exp Biol Med (Maywood) 2016;241:140-6.
19. Chen M, Lv Z, Jiang S. The effects of triptolide on airway remodelling and transforming growth factor-beta(1)/Smad signalling pathway in ovalbumin-sensitized mice. Immunology 2011;132:376-84.
20. Xiong YY, Wang JS, Wu FH, Li J, Kong LY. The effects of (+/-)-Praeruptorin A on airway inflammation, remodeling and transforming growth factor-beta1/Smad signaling pathway in a murine model of allergic asthma. Int Immunopharmacol 2012;14:392-400.
21. Lin CH, Shen ML, Kao ST, Wu DC. The effect of sesamin on airway fibrosis in vitro and in vivo. Int Immunopharmacol 2014;22:141-50.
22. Tarkowski M, Vanoirbeek JA, Vanhooren HM, De Vooght V, Mercier CM, Ceuppens J, et al. Immunological determinants of ventilatory changes induced in mice by dermal sensitization and respiratory challenge with toluene diisocyanate. Am J Physiol Lung Cell Mol Physiol 2007;292:L207-14.
23. Kruger NJ. The Bradford method for protein quantitation. Methods Mol Biol 1994;32:9-15.
24. Padrid P, Snook S, Finucane T, Shiue P, Cozzi P, Solway J, et al. Persistent airway hyperresponsiveness and histologic alterations after chronic antigen challenge in cats. Am J Respir Crit Care Med 1995; 151:184-93.
25. Rhee CK, Kim JW, Park CK, Kim JS, Kang JY, Kim SJ, et al. Effect of imatinib on airway smooth muscle thickening in a murine model of chronic asthma. Int Arch Allergy Immunol 2011;155:243-51.
26. Rhee CK, Kang JY, Park CK, Lee SY, Kwon SS, Kim YK, et al. Effect of nilotinib on airway remodeling in a murine model of chronic asthma. Exp Lung Res 2014;40:199-210.
27. Royce SG, Tang ML. The effects of current therapies on airway remodeling in asthma and new possibilities for treatment and prevention. Curr Mol Pharmacol 2009;2:169-81.
28. Groneberg DA, Witt H, Adcock IM, Hansen G, Springer J. Smads as intracellular mediators of airway inflammation. Exp Lung Res 2004;30:223-50.
29. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003;425:577-84.
30. Qu ZH, Yang ZC, Chen L, Lv ZD, Yi MJ, Ran N. Inhibition airway remodeling and transforming growth factor-beta1/Smad signaling pathway by astragalus extract in asthmatic mice. Int J Mol Med 2012;29:564-8.
31. Yang ZC, Yi MJ, Ran N, Wang C, Fu P, Feng XY, et al. Transforming growth factorbeta1 induces bronchial epithelial cells to mesenchymal transition by activating the Snail pathway and promotes airway remodeling in asthma. Mol Med Rep 2013;8:1663-8.
32. Gong JH, Cho IH, Shin D, Han SY, Park SH, Kang YH. Inhibition of airway epithelial-to-mesenchymal transition and fibrosis by kaempferol in endotoxin-induced epithelial cells and ovalbuminsensitized mice. Lab Invest 2014;94:297-308.